ID   BLK_HUMAN               Reviewed;         505 AA.
AC   P51451; Q16291; Q96IN1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 3.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Tyrosine-protein kinase Blk;
DE            EC=2.7.10.2;
DE   AltName: Full=B lymphocyte kinase;
DE   AltName: Full=p55-Blk;
GN   Name=BLK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7822795;
RA   Islam K.B., Rabbani H., Larsson C., Sanders R., Smith C.I.;
RT   "Molecular cloning, characterization, and chromosomal localization of
RT   a human lymphoid tyrosine kinase related to murine Blk.";
RL   J. Immunol. 154:1265-1272(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7845672;
RA   Drebin J.A., Hartzell S.W., Griffin C., Campbell M.J.,
RA   Niederhuber J.E.;
RT   "Molecular cloning and chromosomal localization of the human homologue
RT   of a B-lymphocyte specific protein tyrosine kinase (blk).";
RL   Oncogene 10:477-486(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH CBL.
RX   PubMed=8083187;
RA   Donovan J.A., Wange R.L., Langdon W.Y., Samelson L.E.;
RT   "The protein product of the c-cbl protooncogene is the 120-kDa
RT   tyrosine-phosphorylated protein in Jurkat cells activated via the T
RT   cell antigen receptor.";
RL   J. Biol. Chem. 269:22921-22924(1994).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF FCGR2A; FCGR2B AND FCGR2C.
RX   PubMed=8756631; DOI=10.1128/MCB.16.9.4735;
RA   Bewarder N., Weinrich V., Budde P., Hartmann D., Flaswinkel H.,
RA   Reth M., Frey J.;
RT   "In vivo and in vitro specificity of protein tyrosine kinases for
RT   immunoglobulin G receptor (FcgammaRII) phosphorylation.";
RL   Mol. Cell. Biol. 16:4735-4743(1996).
RN   [8]
RP   INDUCTION.
RX   PubMed=10553071;
RA   Akerblad P., Sigvardsson M.;
RT   "Early B cell factor is an activator of the B lymphoid kinase promoter
RT   in early B cell development.";
RL   J. Immunol. 163:5453-5461(1999).
RN   [9]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12023895; DOI=10.1042/BJ20011696;
RA   Lang M.L., Chen Y.W., Shen L., Gao H., Lang G.A., Wade T.K.,
RA   Wade W.F.;
RT   "IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases,
RT   phosphoinositide kinases and serine/threonine kinases to glycolipid
RT   rafts.";
RL   Biochem. J. 364:517-525(2002).
RN   [10]
RP   FUNCTION AS REGULATOR OF INSULIN SECRETION, TISSUE SPECIFICITY,
RP   INVOLVEMENT IN MODY11, VARIANT THR-71, AND CHARACTERIZATION OF VARIANT
RP   THR-71.
RX   PubMed=19667185; DOI=10.1073/pnas.0906474106;
RA   Borowiec M., Liew C.W., Thompson R., Boonyasrisawat W., Hu J.,
RA   Mlynarski W.M., El Khattabi I., Kim S.H., Marselli L., Rich S.S.,
RA   Krolewski A.S., Bonner-Weir S., Sharma A., Sale M., Mychaleckyj J.C.,
RA   Kulkarni R.N., Doria A.;
RT   "Mutations at the BLK locus linked to maturity onset diabetes of the
RT   young and beta-cell dysfunction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:14460-14465(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-48; THR-71 AND THR-71.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine kinase involved in B-lymphocyte
CC       development, differentiation and signaling. B-cell receptor (BCR)
CC       signaling requires a tight regulation of several protein tyrosine
CC       kinases and phosphatases, and associated coreceptors. Binding of
CC       antigen to the B-cell antigen receptor (BCR) triggers signaling
CC       that ultimately leads to B-cell activation. Signaling through BLK
CC       plays an important role in transmitting signals through surface
CC       immunoglobulins and supports the pro-B to pre-B transition, as
CC       well as the signaling for growth arrest and apoptosis downstream
CC       of B-cell receptor. Specifically binds and phosphorylates CD79A at
CC       'Tyr-188'and 'Tyr-199', as well as CD79B at 'Tyr-196' and 'Tyr-
CC       207'. Phosphorylates also the immunoglobulin G receptors FCGR2A,
CC       FCGR2B and FCGR2C. With FYN and LYN, plays an essential role in
CC       pre-B-cell receptor (pre-BCR)-mediated NF-kappa-B activation.
CC       Contributes also to BTK activation by indirectly stimulating BTK
CC       intramolecular autophosphorylation. In pancreatic islets, acts as
CC       a modulator of beta-cells function through the up-regulation of
CC       PDX1 and NKX6-1 and consequent stimulation of insulin secretion in
CC       response to glucose. {ECO:0000269|PubMed:19667185,
CC       ECO:0000269|PubMed:8756631}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- ENZYME REGULATION: Antibody-mediated surface engagement of the B-
CC       cell antigen receptor (BCR) which results in the phosphorylation
CC       of BLK on tyrosine residues, stimulates the enzymatic activity.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CBL (via SH2 domain). Interacts with CD79A
CC       and CD79B (via SH2 domain) (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=3; IntAct=EBI-2105445, EBI-608057;
CC       P00533:EGFR; NbExp=2; IntAct=EBI-2105445, EBI-297353;
CC       Q13480:GAB1; NbExp=3; IntAct=EBI-2105445, EBI-517684;
CC       P10721:KIT; NbExp=5; IntAct=EBI-2105445, EBI-1379503;
CC       P40763:STAT3; NbExp=5; IntAct=EBI-2105445, EBI-518675;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor
CC       {ECO:0000250}. Note=Present and active in lipid rafts. Membrane
CC       location is required for the phosphorylation of CD79A and CD79B
CC       (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in lymphatic organs, pancreatic
CC       islets, Leydig cells, striate ducts of salivary glands and hair
CC       follicles. {ECO:0000269|PubMed:19667185}.
CC   -!- INDUCTION: Expression is under the control of NF-kappa-B as well
CC       as the B-cell specific transcription factors PAX5 and EBF1.
CC       {ECO:0000269|PubMed:10553071}.
CC   -!- PTM: Phosphorylated on tyrosine residues after antibody-mediated
CC       surface engagement of the B-cell antigen receptor (BCR).
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitination of activated BLK by the UBE3A ubiquitin
CC       protein ligase leads to its degradation by the ubiquitin-
CC       proteasome pathway. {ECO:0000250}.
CC   -!- DISEASE: Maturity-onset diabetes of the young 11 (MODY11)
CC       [MIM:613375]: A form of diabetes that is characterized by an
CC       autosomal dominant mode of inheritance, onset in childhood or
CC       early adulthood (usually before 25 years of age), a primary defect
CC       in insulin secretion and frequent insulin-independence at the
CC       beginning of the disease. {ECO:0000269|PubMed:19667185}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z33998; CAA83965.1; -; mRNA.
DR   EMBL; S76617; AAB33265.1; -; mRNA.
DR   EMBL; AK313751; BAG36491.1; -; mRNA.
DR   EMBL; CH471157; EAW65617.1; -; Genomic_DNA.
DR   EMBL; BC007371; AAH07371.1; -; mRNA.
DR   EMBL; BC032413; AAH32413.1; -; mRNA.
DR   CCDS; CCDS5982.1; -.
DR   PIR; I37206; I37206.
DR   RefSeq; NP_001706.2; NM_001715.2.
DR   UniGene; Hs.146591; -.
DR   ProteinModelPortal; P51451; -.
DR   SMR; P51451; -.
DR   BioGrid; 107109; 52.
DR   IntAct; P51451; 54.
DR   MINT; MINT-1494192; -.
DR   STRING; 9606.ENSP00000259089; -.
DR   BindingDB; P51451; -.
DR   ChEMBL; CHEMBL2250; -.
DR   GuidetoPHARMACOLOGY; 1940; -.
DR   iPTMnet; P51451; -.
DR   PhosphoSitePlus; P51451; -.
DR   BioMuta; BLK; -.
DR   DMDM; 158936749; -.
DR   PaxDb; P51451; -.
DR   PeptideAtlas; P51451; -.
DR   PRIDE; P51451; -.
DR   DNASU; 640; -.
DR   Ensembl; ENST00000259089; ENSP00000259089; ENSG00000136573.
DR   GeneID; 640; -.
DR   KEGG; hsa:640; -.
DR   UCSC; uc003wty.4; human.
DR   CTD; 640; -.
DR   DisGeNET; 640; -.
DR   GeneCards; BLK; -.
DR   H-InvDB; HIX0007315; -.
DR   H-InvDB; HIX0168887; -.
DR   HGNC; HGNC:1057; BLK.
DR   HPA; CAB005093; -.
DR   MalaCards; BLK; -.
DR   MIM; 191305; gene.
DR   MIM; 613375; phenotype.
DR   neXtProt; NX_P51451; -.
DR   OpenTargets; ENSG00000136573; -.
DR   Orphanet; 552; MODY.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   PharmGKB; PA25368; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118938; -.
DR   HOGENOM; HOG000233858; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P51451; -.
DR   KO; K08890; -.
DR   OMA; GYYKNNM; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; P51451; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P51451; -.
DR   SIGNOR; P51451; -.
DR   ChiTaRS; BLK; human.
DR   GeneWiki; Tyrosine-protein_kinase_BLK; -.
DR   GenomeRNAi; 640; -.
DR   PRO; PR:P51451; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000136573; -.
DR   CleanEx; HS_BLK; -.
DR   ExpressionAtlas; P51451; baseline and differential.
DR   Genevisible; P51451; HS.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0005102; F:receptor binding; IBA:GO_Central.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Diabetes mellitus;
KW   Kinase; Lipoprotein; Membrane; Myristate; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; SH2 domain;
KW   SH3 domain; Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    505       Tyrosine-protein kinase Blk.
FT                                /FTId=PRO_0000088061.
FT   DOMAIN       58    118       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      124    220       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      241    494       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     247    255       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    360    360       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     269    269       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     389    389       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   LIPID         2      2       N-myristoyl glycine. {ECO:0000250}.
FT   VARIANT      48     48       T -> I (in dbSNP:rs35339715).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041672.
FT   VARIANT      71     71       A -> T (associated with MODY11; reduces
FT                                the enhancing effect of BLK on insulin
FT                                secretion; reduces the inducing effect of
FT                                BLK on the expression of PDX1 and NKX6-1;
FT                                found as somatic mutation in a colorectal
FT                                adenocarcinoma sample; dbSNP:rs55758736).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:19667185}.
FT                                /FTId=VAR_041673.
FT   CONFLICT    287    287       V -> M (in Ref. 1; CAA83965).
FT                                {ECO:0000305}.
FT   CONFLICT    407    407       I -> Y (in Ref. 2; AAB33265).
FT                                {ECO:0000305}.
SQ   SEQUENCE   505 AA;  57706 MW;  B5F739BEF8389176 CRC64;
     MGLVSSKKPD KEKPIKEKDK GQWSPLKVSA QDKDAPPLPP LVVFNHLTPP PPDEHLDEDK
     HFVVALYDYT AMNDRDLQML KGEKLQVLKG TGDWWLARSL VTGREGYVPS NFVARVESLE
     MERWFFRSQG RKEAERQLLA PINKAGSFLI RESETNKGAF SLSVKDVTTQ GELIKHYKIR
     CLDEGGYYIS PRITFPSLQA LVQHYSKKGD GLCQRLTLPC VRPAPQNPWA QDEWEIPRQS
     LRLVRKLGSG QFGEVWMGYY KNNMKVAIKT LKEGTMSPEA FLGEANVMKA LQHERLVRLY
     AVVTKEPIYI VTEYMARGCL LDFLKTDEGS RLSLPRLIDM SAQIAEGMAY IERMNSIHRD
     LRAANILVSE ALCCKIADFG LARIIDSEYT AQEGAKFPIK WTAPEAIHFG VFTIKADVWS
     FGVLLMEVVT YGRVPYPGMS NPEVIRNLER GYRMPRPDTC PPELYRGVIA ECWRSRPEER
     PTFEFLQSVL EDFYTATERQ YELQP
//
